New Surescripts contracts not enough to escape FTC lawsuit, judge rules

Surescripts’ new contracts could still be anticompetitive despite the company removing certain provisions in an attempt to fend off a Federal Trade Commission lawsuit alleging it monopolised the market for e-prescription services, a federal judge has ruled.

Unlock unlimited access to all Global Competition Review content